Rhumbline Advisers Cor Medix Inc. Call Options Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRMD
# of Institutions
101Shares Held
16.9MCall Options Held
70.5KPut Options Held
358K-
Black Rock Inc. New York, NY3.55MShares$24.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$20.2 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl1.55MShares$10.8 Million0.04% of portfolio
-
Nomura Holdings Inc Tokyo, M01.42MShares$9.88 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.27MShares$8.84 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $286M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...